United States
Germany
Japan
United Kingdom
China
SLC39A6 (NM_012319) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC216107L1V
- LentiORF®
-
Lenti ORF particles, SLC39A6 (Myc-DDK-tagged)-Human solute carrier family 39 (zinc transporter), member 6 (SLC39A6), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 14,155.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | SLC39A6 (NM_012319) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | LIV-1; ZIP6 |
| Vector | pLenti-C-Myc-DDK |
| ACCN | NM_012319 |
| ORF Size | 2265 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC216107).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_012319.3, NP_036451.3 |
| RefSeq Size | 3637 bp |
| RefSeq ORF | 2268 bp |
| Locus ID | 25800 |
| Domains | Zip |
| Protein Families | Druggable Genome, Transmembrane |
| MW | 84.9 kDa |
| Gene Summary | Zinc is an essential cofactor for hundreds of enzymes. It is involved in protein, nucleic acid, carbohydrate, and lipid metabolism, as well as in the control of gene transcription, growth, development, and differentiation. SLC39A6 belongs to a subfamily of proteins that show structural characteristics of zinc transporters (Taylor and Nicholson, 2003 [PubMed 12659941]).[supplied by OMIM, Mar 2008] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
其它SLC39A6产品
Customer
Reviews
Loading...
